The Role of Vaspin in the Development of Metabolic and Glucose Tolerance Disorders and Atherosclerosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Vaspin in the Development of Metabolic and Glucose Tolerance Disorders and Atherosclerosis
Authors
Keywords
-
Journal
Biomed Research International
Volume 2015, Issue -, Pages 1-7
Publisher
Hindawi Limited
Online
2015-04-08
DOI
10.1155/2015/823481
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum vaspin levels are positively associated with carotid atherosclerosis in a general population
- (2014) Eishi Esaki et al. ATHEROSCLEROSIS
- Higher vaspin levels in subjects with obesity and type 2 diabetes mellitus: A meta-analysis
- (2014) Rennan Feng et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Vaspin (serpinA12) in obesity, insulin resistance, and inflammation
- (2014) John T. Heiker JOURNAL OF PEPTIDE SCIENCE
- Role of Serum Vaspin in Progression of Type 2 Diabetes: A 2-Year Cohort Study
- (2014) Weixia Jian et al. PLoS One
- Adipokines – removing road blocks to obesity and diabetes therapy
- (2014) Matthias Blüher Molecular Metabolism
- Association of Vaspin with Metabolic Syndrome: The Pivotal Role of Insulin Resistance
- (2014) Alireza Esteghamati et al. Diabetes & Metabolism Journal
- Vaspin inhibits kallikrein 7 by serpin mechanism
- (2013) John T. Heiker et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Visceral Adipose Tissue-derived Serine Proteinase Inhibitor Inhibits Apoptosis of Endothelial Cells as a Ligand for the Cell-Surface GRP78/Voltage-dependent Anion Channel Complex
- (2013) Atsuko Nakatsuka et al. CIRCULATION RESEARCH
- Adipokines in obesity
- (2013) Viviane de Oliveira Leal et al. CLINICA CHIMICA ACTA
- Vaspin inhibited proinflammatory cytokine induced activation of nuclear factor-kappa B and its downstream molecules in human endothelial EA.hy926 cells
- (2013) Shiwei Liu et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- A Novel Adipocytokine, Visceral Adipose Tissue-derived Serine Protease Inhibitor (Vaspin), and Obesity
- (2013) Q Li et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Vaspin Serum Concentration in Patients with Type 2 Diabetes and Carotid Plaque
- (2013) Z Li et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Investigation of Vaspin Level in Patients with Acute Ischemic Stroke
- (2013) Hasan S. Cura et al. Journal of Stroke & Cerebrovascular Diseases
- Association Between Serum Vaspin Level and Metabolic Syndrome in Healthy Korean Subjects
- (2013) Jung Min Kim et al. Metabolic Syndrome and Related Disorders
- Vaspin Is an Adipokine Ameliorating ER Stress in Obesity as a Ligand for Cell-Surface GRP78/MTJ-1 Complex
- (2012) A. Nakatsuka et al. DIABETES
- Genetic variation in the vaspin gene affects circulating serum vaspin concentrations
- (2012) J Breitfeld et al. INTERNATIONAL JOURNAL OF OBESITY
- Serum Vaspin Concentrations Are Closely Related to Insulin Resistance, and rs77060950 atSERPINA12Genetically Defines Distinct Group with Higher Serum Levels in Japanese Population
- (2012) Sanae Teshigawara et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women
- (2011) Teresa Auguet et al. BMC Medical Genetics
- Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women
- (2011) Sung Hee Choi et al. CLINICAL ENDOCRINOLOGY
- Two Patterns of Adipokine and Other Biomarker Dynamics in a Long-Term Weight Loss Intervention
- (2011) M. Bluher et al. DIABETES CARE
- Impact of circulating vaspin levels on metabolic variables in elderly twins
- (2011) K. Hida et al. DIABETOLOGIA
- Short-term continuous subcutaneous insulin infusion decreases the plasma vaspin levels in patients with type 2 diabetes mellitus concomitant with improvement in insulin sensitivity
- (2011) Ke Li et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Lifestyle modification increases circulating adiponectin concentrations but does not change vaspin concentrations
- (2011) Seon Mee Kim et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Serum levels of vaspin and visfatin in patients with coronary artery disease—Kozani study
- (2010) Nikolaos P.E. Kadoglou et al. CLINICA CHIMICA ACTA
- Circadian Rhythm of Serum Vaspin in Healthy Male Volunteers: Relation to Meals
- (2010) Eunheui Jeong et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association between serum vaspin concentrations and visceral adipose tissue in Korean subjects
- (2010) Hye Mi Chang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus
- (2010) Hala O. El-Mesallamy et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effects of Weight Reduction on Serum Vaspin Concentrations in Obese Subjects: Modification by Insulin Resistance
- (2010) Hye M. Chang et al. Obesity
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification
- (2009) Mi Kyung Lee et al. CLINICA CHIMICA ACTA
- Vaspin and its correlation with insulin sensitivity indices in obese children
- (2009) Selami Suleymanoglu et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans
- (2009) Christian von Loeffelholz et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Current strategies for the inhibition of hepatic glucose production in type 2 diabetes
- (2009) Dale et al. Frontiers in Bioscience-Landmark
- Regulation of visceral adipose tissue-derived serine protease inhibitor by nutritional status, metformin, gender and pituitary factors in rat white adipose tissue
- (2009) C. R. González et al. JOURNAL OF PHYSIOLOGY-LONDON
- Serum Vaspin Concentrations in Relation to Insulin Sensitivity Following RYGB-Induced Weight Loss
- (2009) Ammon Handisurya et al. OBESITY SURGERY
- The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology
- (2008) Jean-Pierre Després et al. ANNALS OF MEDICINE
- Vaspin serum concentrations in patients with carotid stenosis
- (2008) Gabriela Aust et al. ATHEROSCLEROSIS
- Metformin Decreases the Adipokine Vaspin in Overweight Women With Polycystic Ovary Syndrome Concomitant With Improvement in Insulin Sensitivity and a Decrease in Insulin Resistance
- (2008) B. K. Tan et al. DIABETES
- Serum vaspin levels in type 2 diabetic women in relation to microvascular complications
- (2008) Nese Ersoz Gulcelik et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Vaspin (SERPINA12) Genotypes and Risk of Type 2 Diabetes: Results from the MONICA/KORA studies
- (2008) K. Kempf et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Vaspin: a novel serpin with insulin-sensitizing effects
- (2008) Jun Wada EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue
- (2008) John N. Fain et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Serum Levels of the Adipokine Vaspin in Relation to Metabolic and Renal Parameters
- (2007) Jeannette Seeger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now